Immunome, Inc.
8 of the Top-200 alpha managers hold $IMNM as of the latest 13F snapshot.
Smart Money · top-200 alpha cohort
8 holders · Q1 2026$IMNM is held by 8 managers from the Top-Performer cohort as of Q1 2026. Position weights range from 0.00% to 22.48%, with an average of 2.82% of portfolio. Largest holder: Enavate Sciences GP, LLC at 22.48%. A weekly Smart-Money commentary for this ticker has not been generated yet this batch — the table below shows the full cohort positioning.
Smart Money shows holdings from our Top-Performer cohort — the 200 highest-alpha manager_13f funds in our universe. Position weight (current quarter) and QoQ delta versus prior quarter. α is the manager's annual alpha vs benchmark.
Institutional holders
Top 10 of 194 · Source: 13F-HRInsider activity · last 90 days
12 transactions · 4 filersTransaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.
Congress trades · last 90 days
No STOCK Act filings reference $IMNM in the recent window.
Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 06:56 UTC.